1. Белов Б.С., Балабанова Р.М., Манукян С.Г., Полянская М.В. Коморбидные инфекции при ревматических заболеваниях. Науч.-практ. ревматол. 2006; 3: 62–6.
2. Лучихина Е.Л., Каратеев Д.Е., Соловьев С.К., Иванова М.М. Структура летальных исходов при системной красной волчанке по данным Института ревматологии РАМН. Рос. ревматол. 1998; 3: 2–9.
3. Заболеваемость населения России в 2009 году. Статистические материалы. Ч. 1. М., 2010; с. 32.
4. Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. М., 2010.
5. Martin-Suarez I, D’Cruz D, Mansoor M et al. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis 1997; 56: 481–7.
6. Gladman DD, Hussain F, Iban D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002; 11: 234–9.
7. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-a therapy. Rheumatology 2003; 42: 617–21.
8. Gluck T, Kiefmann B, Grohmann M et al. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 2005; 32 (8): 1473–80.
9. Ng WL, Chu CM, Wu AKL et al. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. Q J Med 2006; 99: 37–47.
10. Reddy S, Wanchu A, Gupta V, Bambery P. Profile of opportunistic infections among patients on immunosuppressive medication. APLAR J Rheumatol 2006; 9: 269–74.
11. Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology 2007; 46: 1157–60.
12. Franklin J, Lunt M, Bunn D et al. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007; 66: 308–12.
13. Smitten AL, Choi HK, Hochberg MC et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 2008; 35 (3): 387–93.
14. Mandell LA, Wunderink RG, Anzueto A et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 2): S27–72.
15. El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 645–51.
16. Guidelines for the Management of Adults with Community-acquired Pneumonia. Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. Official statement of the American Thoracic Society. Am J Respir Crit Care Med 2001; 163: 1730–54.
17. Чучалин А.Г., Синопальников А.И., Страчунский Л.С. Пневмония. М.: Мед. информ. агентство, 2006.
18. Bosch X, Guilabert A, Pallarés L et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006; 15: 584–9.
19. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia. Arthritis Rheum 2006; 54 (2): 628–34.
20. Полянская М.В. Пневмония у пациентов с ревматическими заболеваниями: частота встречаемости, клиническая картина, факторы риска. Автореф. дис. ... канд. мед. наук. М., 2009.
21. Coyne P, Hamilton J, Heycock C et al. Acute lower respiratory tract infections in patients with rheumatoid arthritis. J Rheumatol 2007; 34 (9): 1832–6.
22. Narata R, Wangkaew S, Kasitanon N, Louthrenoo W. Community-acquired pneumonia in Thai patients with systemic lupus erythematosus. Southeast Asian J Trop Med Public Health 2007; 38 (3): 528–36.
23. Kinder BW, Freemer MM, King-Jr. TE et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum 2007; 56 (8): 2679–86.
24. Pascual-Ramos V, Hernandez-Hernandez C, Soto-Rojas AE et al. Association between dental caries and pneumonia in patients with systemic lupus erythematosus. J Rheumatol 2006; 33 (10): 1996–2002.
25. Estrach C, Moots RJ, Andrews S et al. High incidence of pneumonia in patients on anti-TNF therapy. Rheumatology 2002; 41 (Suppl. 1): 93.
26. Listing J, Strangfeld A, Kary S et al. Infections in Patients With Rheumatoid Arthritis Treated With Biologic Agents. Arthritis Rheum 2005; 52 (11): 3403–12.
27. Salliot C, Gossec L, Ruyssen-Witrand A et al. Infections during tumour necrosis factor blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Rheumatology 2007; 46: 327–34.
28. Hoshi D, Nakajima A, Inoue E et al. Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Mod Rheumatol 2011, Jul 8. [Epub ahead of print]
29. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 1999; 42 (4): 780–9.
30. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002; 34 (8): 1098–107.
31. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995; 162 (5): 233–5.
32. Stamp LK, Hurst M. Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases? J Rheumatol 2010; 37 (4): 686–8.
33. van Assen S, Agmon-Levin N, Elkayam O et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011; 70 (3): 414–22.
34. Kavanaugh A. Infection prophylaxis in antirheumatic therapy: emphasis on vaccination. Curr Opin Rheumatol 2009; 21 (4): 419–24.

Б.С.Белов, М.В.Полянская, Г.М.Тарасова, М.С.Наумцева

Научно-исследовательский институт ревматологии РАМН, Москва